What is the share price of Genpharmasec Ltd (GENPHARMA) today?
The share price of GENPHARMA as on 1st July 2025 is ₹2.08. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Genpharmasec Ltd (GENPHARMA) share?
The past returns of Genpharmasec Ltd (GENPHARMA) share are- Past 1 week: N/A%
- Past 1 month: -5.09%
- Past 3 months: 8.95%
- Past 6 months: -38.39%
- Past 1 year: -4.17%
- Past 3 years: -39.06%
- Past 5 years: -73.49%
What are the peers or stocks similar to Genpharmasec Ltd (GENPHARMA)?
The peers or stocks similar to Genpharmasec Ltd (GENPHARMA) include:What is the market cap of Genpharmasec Ltd (GENPHARMA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genpharmasec Ltd (GENPHARMA) is ₹114.62 Cr as of 1st July 2025.What is the 52 week high and low of Genpharmasec Ltd (GENPHARMA) share?
The 52-week high of Genpharmasec Ltd (GENPHARMA) is ₹4.32 and the 52-week low is ₹1.89.What is the PE and PB ratio of Genpharmasec Ltd (GENPHARMA) stock?
The P/E (price-to-earnings) ratio of Genpharmasec Ltd (GENPHARMA) is 93.19. The P/B (price-to-book) ratio is 1.78.Which sector does Genpharmasec Ltd (GENPHARMA) belong to?
Genpharmasec Ltd (GENPHARMA) belongs to the Industrials sector & Commodities Trading sub-sector.How to buy Genpharmasec Ltd (GENPHARMA) shares?
You can directly buy Genpharmasec Ltd (GENPHARMA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Genpharmasec Ltd
GENPHARMA Share Price
2.081.46% (+0.03)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GENPHARMA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GENPHARMA Performance & Key Metrics
GENPHARMA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 74.43 | 1.78 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 39.05 | 6.60 | 0.56% |
GENPHARMA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GENPHARMA Company Profile
Generic Pharmasec Ltd is an India-based company. The Company is focused on trading and dealing in chemicals.
ADANIENT
PE Ratio
42.55
42.55
1Y Return
17.65%
17.65%
Buy Reco %
100.00
100.00
MMTC
PE Ratio
124.67
124.67
1Y Return
8.01%
8.01%
Buy Reco %
0.00
0.00
MSTCLTD
PE Ratio
9.34
9.34
1Y Return
35.95%
35.95%
Buy Reco %
0.00
0.00
PE Ratio
4,825.12
4,825.12
1Y Return
1,020.80%
1,020.80%
Buy Reco %
0.00
0.00
PE Ratio
11.09
11.09
1Y Return
26.22%
26.22%
Buy Reco %
0.00
0.00
GENPHARMA Forecast
GENPHARMA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GENPHARMA
GENPHARMA
Income
Balance Sheet
Cash Flow
Annual Normal View
GENPHARMA Income Statement
GENPHARMA Income Statement
Annual Normal View
| Financial Year | FY 2023 | FY 2024 | FY 2025 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 25.62 | 31.07 | 36.78 | 36.79 | ||||
Raw Materials | 23.18 | 23.40 | 33.66 | 33.66 | ||||
| Power & Fuel Cost | 0.00 | 0.00 | ||||||
| Employee Cost | 0.54 | 0.76 | ||||||
| Selling & Administrative Expenses | 0.95 | 3.36 | ||||||
| Operating & Other expenses | 0.58 | 2.84 | ||||||
EBITDA | 0.37 | 0.71 | 3.12 | 3.13 | ||||
| Depreciation/Amortization | 0.02 | 0.04 | 0.81 | 0.82 | ||||
| PBIT | 0.35 | 0.67 | 2.31 | 2.31 | ||||
| Interest & Other Items | 0.06 | 0.41 | 0.43 | 0.44 | ||||
| PBT | 0.29 | 0.26 | 1.88 | 1.87 | ||||
| Taxes & Other Items | -0.84 | 0.38 | 0.65 | 0.33 | ||||
| Net Income | 1.13 | -0.12 | 1.23 | 1.54 | ||||
| EPS | 0.02 | -0.00 | 0.01 | 0.03 | ||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 |
GENPHARMA Company Updates
GENPHARMA Stock Peers
GENPHARMA Past Performance & Peer Comparison
GENPHARMA Past Performance & Peer Comparison
Comparing 3 stocks from
IndustrialsCommodities Trading
Compare valuation-basic on Screener
IndustrialsCommodities Trading
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Genpharmasec Ltd | 93.19 | 1.78 | — |
| Adani Enterprises Ltd | 42.55 | 5.36 | 0.05% |
| MMTC Ltd | 124.67 | 6.64 | — |
| MSTC Ltd | 9.34 | 4.28 | 6.67% |
GENPHARMA Stock Price Comparison
Compare GENPHARMA with any stock or ETFCompare GENPHARMA with any stock or ETF
GENPHARMA
GENPHARMA Holdings
GENPHARMA Shareholdings
GENPHARMA Promoter Holdings Trend
GENPHARMA Promoter Holdings Trend
GENPHARMA Institutional Holdings Trend
GENPHARMA Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 2.29%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GENPHARMA Shareholding Pattern
GENPHARMA Shareholding Pattern
GENPHARMA Shareholding History
GENPHARMA Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing GENPHARMA stock
smallcases containing GENPHARMA stock
Looks like this stock is not in any smallcase yet.
GENPHARMA Events
GENPHARMA Events
GENPHARMA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GENPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GENPHARMA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GENPHARMA has not given any dividends in last 5 years
GENPHARMA Dividends
GENPHARMA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGENPHARMA Stock News & Opinions
GENPHARMA Stock News & Opinions
Articles & Videos
Earnings
Genpharmasec reports consolidated net loss of Rs 0.27 crore in the March 2025 quarter
Net Loss of Genpharmasec reported to Rs 0.27 crore in the quarter ended March 2025 as against net loss of Rs 0.27 crore during the previous quarter ended March 2024. Sales rose 37.35% to Rs 14.01 crore in the quarter ended March 2025 as against Rs 10.20 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 1.23 crore in the year ended March 2025 as against net loss of Rs 0.17 crore during the previous year ended March 2024. Sales rose 10.88% to Rs 33.72 crore in the year ended March 2025 as against Rs 30.41 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales14.0110.20 37 33.7230.41 11 OPM %-7.14-0.10 -0.210.13 - PBDT-0.170.14 PL 2.690.29 828 PBT-0.430.11 PL 1.880.25 652 NP-0.27-0.27 0 1.23-0.17 LP Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Genpharmasec to table results
Genpharmasec will hold a meeting of the Board of Directors of the Company on 21 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Genpharmasec to hold board meeting
Genpharmasec will hold a meeting of the Board of Directors of the Company on 24 March 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Genpharmasec consolidated net profit rises 1200.00% in the December 2024 quarter
Net profit of Genpharmasec rose 1200.00% to Rs 0.78 crore in the quarter ended December 2024 as against Rs 0.06 crore during the previous quarter ended December 2023. Sales rose 32.92% to Rs 8.48 crore in the quarter ended December 2024 as against Rs 6.38 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales8.486.38 33 OPM %8.730.31 - PBDT1.390.15 827 PBT1.290.03 4200 NP0.780.06 1200 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Genpharmasec to declare Quarterly Results
Genpharmasec will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Genpharmasec consolidated net profit rises 6900.00% in the September 2024 quarter
Net profit of Genpharmasec rose 6900.00% to Rs 0.70 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales declined 23.28% to Rs 6.03 crore in the quarter ended September 2024 as against Rs 7.86 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales6.037.86 -23 OPM %1.99-0.51 - PBDT0.810.05 1520 PBT0.500.05 900 NP0.700.01 6900 Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Genpharmasec standalone net profit rises 9900.00% in the September 2024 quarter
Net profit of Genpharmasec rose 9900.00% to Rs 1.00 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales declined 26.59% to Rs 5.77 crore in the quarter ended September 2024 as against Rs 7.86 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.777.86 -27 OPM %4.33-0.38 - PBDT1.070.05 2040 PBT1.030.05 1960 NP1.000.01 9900 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Genpharmasec announces board meeting date
Genpharmasec will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Genpharmasec standalone net profit rises 1866.67% in the June 2024 quarter
Net profit of Genpharmasec rose 1866.67% to Rs 0.59 crore in the quarter ended June 2024 as against Rs 0.03 crore during the previous quarter ended June 2023. Sales declined 11.07% to Rs 5.30 crore in the quarter ended June 2024 as against Rs 5.96 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales5.305.96 -11 OPM %4.150.50 - PBDT0.730.08 813 PBT0.730.07 943 NP0.590.03 1867 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Genpharmasec to conduct board meeting
Genpharmasec will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant